University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Veterans Affairs Medical Center, Oklahoma City, OK, USA.
Osteoporos Int. 2017 Oct;28(10):2801-2812. doi: 10.1007/s00198-017-4170-5. Epub 2017 Aug 4.
Rheumatoid arthritis (RA) is associated with local and systemic inflammation that induces many changes in the skeletal health. Locally, periarticular bone loss and juxta-articular bone erosions may occur while joint ankylosis, generalized bone loss, osteoporosis, and fractures may develop secondary to inflammation. The aim of this narrative review is to summarize the clinical evidence for abnormal skeletal health in RA, the effects of disease modifying anti-rheumatic drugs (DMARDS) on bone health, and the effects of drugs for the prevention or treatment of osteoporosis in the RA population.
类风湿关节炎(RA)与局部和全身炎症有关,这些炎症会导致骨骼健康发生许多变化。局部可能发生关节周围骨丢失和关节旁骨侵蚀,而关节强直、全身性骨丢失、骨质疏松症和骨折可能因炎症而发生。本综述的目的是总结 RA 患者骨骼健康异常的临床证据、疾病修饰抗风湿药物(DMARDs)对骨骼健康的影响,以及预防或治疗 RA 患者骨质疏松症的药物的影响。